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Abstract: Multiresistance among microorganisms to common antimicrobials has become 
one of the most significant concerns in modern medicine. Nanomaterials are a new alternative 
to successfully treat the multiresistant microorganisms. Nanostructured materials are used in 
many fields, including biological sciences and medicine. Recently, it was demonstrated that 
the bactericidal activity of zero-valent bismuth colloidal nanoparticles inhibited the growth of 
Streptococcus mutans; however the antimycotic potential of bismuth nanostructured derivatives 
has not yet been studied. The main objective of this investigation was to analyze the fungicidal 
activity of bismuth oxide nanoparticles against Candida albicans, and their antibiofilm 
capabilities. Our results showed that aqueous colloidal bismuth oxide nanoparticles displayed 
antimicrobial activity against C. albicans growth (reducing colony size by 85%) and a complete 
inhibition of biofilm formation. These results are better than those obtained with chlorhexidine, 
nystatin, and terbinafine, the most effective oral antiseptic and commercial antifungal agents. In 
this work, we also compared the antimycotic activities of bulk bismuth oxide and bismuth nitrate, 
the precursor metallic salt. These results suggest that bismuth oxide colloidal nanoparticles could 
be a very interesting candidate as a fungicidal agent to be incorporated into an oral antiseptic. 
Additionally, we determined the minimum inhibitory concentration for the synthesized aqueous 
colloidal Bi
2
O
3
 nanoparticles.
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Introduction
The occurrence of microorganisms living in cooperative, aggregated communities is 
called a biofilm. Biofilms can form on many kinds of surfaces and interfaces, including 
the human body.1 The most common biofilms associated with human disease episodes 
are the fungi of the genus Candida, most notably Candida albicans, which causes 
both superficial and systemic disease. C. albicans biofilm is commonly found in 
children and elderly persons with a deficient immune system, and it is the etiological 
agent of oral moniliasis; the mortality of patients with invasive candidiasis can be as 
high as 40%.2,3 Fungal infections are difficult to eradicate, requiring high quantities 
and longtime exposure to an antimycotic agent to efficiently eliminate the etiological 
pathogen.4
Multiresistance among pathogen microorganisms has become one of the most 
important problems in current medicine.5 Since early reports in 1980, new evidence 
has suggested the emergence of multiresistant strains of Candida, suggesting that 
multiresistance is not an exclusive phenomenon of bacteria.6,7 The absence of new 
alternatives to efficiently treat these multiresistant microorganisms is a real problem, 
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and it is urgent to synthesize new broad spectrum drugs to 
fight antimicrobial resistance.
Typically, bismuth is found as bismuthinite (bismuth 
sulfide), bismite (bismuth oxide [Bi
2
O
3
]), and bismuthite 
(bismuth carbonate).8 In medicine, bismuth, in the form of 
bismuth subsalicylate, has been employed as an antidiarrheal 
to treat nauseas, vomiting, and stomach pain.9
The chemistry of the binary oxides of bismuth is 
dominated by the +3 oxidation state. Most of the work 
on bismuth, concentrates on Bi
2
O
3
. Bi
2
O
3
 shows a 
distinctive polymorphism, including the following solid 
state phases: α-Bi
2
O
3
, β-Bi
2
O
3
, γ-Bi
2
O
3
, δ-Bi
2
O
3
, and the 
recently characterized ε-Bi
2
O
3
.10 The α-Bi
2
O
3
 is the most 
thermodynamically stable phase at room temperature and 
pressure. So, under standard reaction conditions in aqueous 
solutions, the α-Bi
2
O
3
 is formed, a poorly water-soluble 
specie that carries surface hydroxyl groups.11 α-Bi
2
O
3
 is a 
basic oxide and its Bi-O bonds are predominantly ionic;12 it 
is a p-type semiconductor material.10
Bi
2
O
3
 is a derivative of great technological importance, 
and it is used in the manufacture of glass and ceramic products, 
and also, as catalyst in the oxidation of hydrocarbons. It is 
widely used in applications, such as microelectronics, and 
sensor and optical technology.13,14
Nanoparticles (NPs) have large surface areas, and 
therefore, they have increased interactions with biological 
targets. We recently demonstrated the antibacterial 
effectiveness of zero-valent bismuth NPs at inhibiting the 
growth of Streptococcus mutans;15 however; at the present 
time the antimycotic potential of bismuth nanostructured 
derivatives are not known. In this report, we present 
evidence of the antimycotic properties of Bi
2
O
3
 NPs against 
the growth of C. albicans and its capability to eliminate the 
fungal biofilm – the biocidal activity of Bi
2
O
3
 NPs was very 
similar to that obtained with chlorhexidine, a commonly 
used oral antiseptic and commercial antifungals as nystatin 
and terbinafine. Additionally, the C. albicans antifungal 
capacities of bulk Bi
2
O
3
 material and bismuth nitrate, the 
precursor salt used in the Bi
2
O
3
 colloidal NPs synthesis, are 
compared.
Materials and methods
Synthesis of Bi2O3 NP
For the synthesis of Bi
2
O
3
 nanoclusters (Bi
2
O
3
 NCs), the 
following chemical reagents were used: bismuth nitrate 
pentahydrate (Bi(NO
3
)
3 
⋅ 5H
2
O), 98% (Sigma-Aldrich, 
St Louis, MO, USA); Bi
2
O
3
, 99.999% trace metals basis 
(Sigma-Aldrich); potassium hydroxide (KOH), 85% (Meyer, 
Tlahuac, Mexico City, Mexico); argon (Ar), 99.998% (Praxair 
Inc, Danbury, CT, USA); and deionized water, 18.2 Ω (Milli 
Q®; Thermo Fisher Scientific, Waltham, MA, USA). These 
chemical substances were used as they were received.
We used a typical preparation method for the production of 
the Bi
2
O
3
 NP colloids, as follows: First, all water to be used in 
the synthesis was boiled and after cooling to room temperature, 
was bubbled with argon gas for 15 minutes in order to prevent 
carbonation. Subsequently, 0.0274 g of Bi(NO
3
)
3 
⋅ 5H
2
O were 
dissolved in 24.5 mL of the prepared water. This solution was 
heated, under vigorous magnetic stirring, at 80°C. Then, 0.5 mL 
of an aqueous solution of KOH 0.032 M were added to the 
Bi(NO
3
)
3 
⋅ 5H
2
O solution. The final concentrations of bismuth 
and hydroxide ions were 2 × 10−3 M and 6 × 10−3 M, respectively. 
It is worth noting that during the entire process of dissolution 
and mixing of the reagents, a weak stream of argon was blowing 
over the surface of the reaction mixture. The newly synthesized 
yellowish Bi
2
O
3
 powder NPs were isolated by centrifugation 
at 14,000 rpm, for 30 minutes. Afterwards, they were washed 
with previously decarbonated water, three times. Finally, the 
powdered Bi
2
O
3
 NPs were once again resuspended in water and 
stored at room temperature for approximately 30 minutes, until 
their use. In order to prove the reproducibility of this synthesis 
method, these colloids were prepared in triplicate.
Characterization of Bi2O3 NPs
The needle-shaped morphology of Bi
2
O
3
 NPs was determined 
by transmission electron (TEM) micrographs obtained using 
a JEOL 1200-EXII (JEOL Ltd, Tokyo, Japan) of 40–120 KV. 
Single drops of the ethanol nanoparticle suspension were 
deposited onto 200 mesh copper grids coated with a carbon/
collodion layer.
The Bi
2
O
3
 monoclinic phase identification was obtained 
from the X-ray diffraction pattern (PDF 41-1449 card), recorded 
on a Bruker D2-Phaser diffractometer (Bruker Corp, Billerica, 
MA, USA), using Cu Kα radiation, 1.5406 Å (30 kV, 10 mA). 
The crystallite size, 77 nm, was determined using the Scherrer 
equation. From the X-ray diffraction pattern and the TEM 
images, we observed needle-shaped crystallites, which indicated 
a textured material (in the 120 direction) (Figure 1).
Antimycotic activity of Bi2O3 NPs 
against C. albicans growth
C. albicans (No 90029) was obtained from the American Type 
Culture Collection, (Manassas, VA, USA). The antifungal effect 
of Bi
2
O
3
 NPs on C. albicans growth was determined using a 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay (Biotium Inc, Hayward, CA, USA),16,17 following 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1646
Hernandez-Delgadillo et al
International Journal of Nanomedicine 2013:8
the instructions of the manufacturer. C. albicans was grown 
in Trypticase™ Soy Broth (TSB) (BD Biosciences, Franklin 
Lakes, NJ, USA) at 37°C, overnight in aerobic conditions. The 
fungal cells were counted, using a Neubauer chamber, and 
1 × 104 cells were inoculated in 100 µL of TSB medium, in a 
96-well polystyrene plate. Three wells with only TSB medium 
were used as controls for growth of C. albicans. Chlorhexidine 
2% (Ultradent Products Inc, South Jordan, UT, USA) was used 
as a positive antimicrobial control; additionally, terbinafine 1% 
(Novartis Pharmaceuticals Corp, Basel, Switzerland) and com-
mercial Bi
2
O
3
 were used as antifungal positive controls.
Hereinafter, the concentrations given refer to the initial 
concentration of the respective bismuth precursor. We 
used 50 µL of a 2 mM of Bi
2
O
3
 NP dispersion, in a total 
volume of 150 µL, to interfere with bacterial growth. As 
additional controls, 2 mM of Bi
2
O
3
 (bulk material) aqueous 
suspension and 2 mM of Bi(NO
3
)
3 
⋅ 5H
2
O aqueous solution 
(the precursor bismuth salt), were added separately to cells, 
to compare the antifungal activities of the metallic salt, 
bulk material, and nanostructured samples. In this research, 
we avoided the use of organic solvents in order to prevent 
possible interference with the antifungal and cytotoxic 
properties of the Bi
2
O
3
 NPs.
The 96-well plate was incubated at 37°C overnight. Next, 
10 µL of MTT was added to each well, and the plate was 
protected against light and incubated at 37°C for 2 hours. 
Next, 200 µL of dimethyl sulfoxide was added to dissolve 
the reduced MTT species. The amount of live cells was 
determined using a microplate absorbance reader (iMark™; 
Bio-Rad Laboratories, Philadelphia, PA, USA), at 595 nm. 
The experiments were repeated three times, and the measured 
optical density was analyzed by descriptive statistics.
Determination of minimal inhibitory 
concentration (MIC) of Bi2O3 NPs
The MIC was determined as described in a previous work.18 Briefly, 
a 5 tube in the McFarland scale, with 1 × 109 CFU, was obtained 
(McFarland scale are fungal solutions. There are 1–9 ranges in this 
scale with a specific number of microbes in each one): C. albicans 
was grown in TSB agar and incubated at 37°C for 24 hours. One 
colony was inoculated in 5 mL of TSB medium and incubated at 
37°C for 24 hours. The fungal count was determined with a Neubauer 
chamber. Tubes with a final concentration of 1 × 106 CFU were 
obtained by dilution of the 5 tube in the McFarland scale. The Bi
2
O
3
 
NP suspension was diluted to final concentrations of 0.25, 0.5, 1, and 
1.5, from the 2 mM stock. Then, 1 mL of each Bi
2
O
3
 NP dispersion 
was mixed with a fungal culture medium and then, incubated at 37°C 
for 18 hours. The MIC was determined by the presence or absence 
of turbidity in the different tubes containing the NPs.
Biofilm inhibitory activity of Bi2O3 NPs
The antibiofilm activity of the Bi
2
O
3
 NPs was determined by 
fluorescence microscopy, following the methodology described 
above. To observe the biofilm, SYTO® 9 green fluorescent 
nucleic acid stain (Life Technologies, Carlsbad, CA, USA) 
was added, to a final concentration of 20 µM.19,20 The 96-well 
plate was incubated for 30 minutes at room temperature and 
protected against light. The C. albicans biofilm was visualized 
with a Carl Zeiss Z1 Axio Inverter microscope (Carl Zeiss 
Meditec, Jena, Germany), at 485 nm.
Cytotoxicity of Bi2O3 NPs on culture 
cells by fluorescence microscopy
It is important to emphasize that we did not find any report con-
cerning cytotoxicity of common bismuth nanostructured deriva-
tives. We found one related publication describing the stability, 
cytotoxicity, and potential use of KBi(H
2
O)
2
[Fe(CN)
6
] 3H
2
O 
NPs – of course, this cyano species is extremely toxic.21
In this research we used monkey kidney (Vero) cells to 
analyze the cytotoxic effect of Bi
2
O
3
 NPs. A confluent monolayer 
of Vero cells (CCL-81; ATTCC) was grown in minimal essential 
media (MEM) (Life Technologies) supplemented with 10% of 
Fetal Bovine Serum (FBS) (Life Technologies), at 37°C with 
5% of CO
2
, in a Nunc® Lab-Tek® Chamber Slide™ System (16 
wells; Thermo Fisher Scientific). This was exposed to 2 mM 
of Bi
2
O
3
 NPs for 24 hours, and the possible cytotoxic effect 
was detected by fluorescence microscopy. For the negative 
control, cells without NPs were employed. The Vero cells were 
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Figure 1 Structural and morphological characterization of Bi2O3 NPs, the crystalline 
habit, and the idealization of the hydroxyl ions and water molecules interactions 
with the -120 surface plane.
Notes: (A) Bi2O3 NPs X-ray diffraction pattern. This sample was synthesized in 
water, as described in the Materials and methods section. In this case, the observed 
peaks match with the α-phase (monoclinic) of Bi2O3. (B) TEM image of the Bi2O3 
NPs clearly shows the needle shape exhibited by these nanoclusters. (C) This model 
shows the crystal structure of a representative particle, with the respective exposed 
planes. (D) The images shows a (−120) plane sketch, in particular, the enhanced 
interaction of bismuth atoms with hydroxyl ions and water molecules.
Abbreviations: Bi2O3, bismuth oxide; NP, nanoparticle; TEM, transmission 
electron microscope.
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washed three times with phosphate-buffered saline (PBS), and 
4′,6-diamidino-2-phenylindole (DAPI) (Abcam Inc, Cambridge, 
UK) was added to stain the nucleus of cells.22 Cytotoxicity was 
interpreted as the presence of a degraded or amorphous nucleus, 
observing at 365 nm with an inverter Carl Zeiss microscope.
Results
Synthesis and characterization 
of Bi2O3 NPs
The colloidal dispersions of Bi
2
O
3
 NPs prepared from 2 × 10−3 M 
Bi(NO
3
)
3 
⋅ 5H
2
O and 6 × 10−3 M of KOH in deionized water 
yielded a fine beige powder with an approximate crystallite 
size of 77 nm. The X-ray diffraction pattern of the Bi
2
O
3
 NP 
powder showed the presence of α-phase nanocrystallites and 
the absence of other possible compounds (like carbonated 
elements) generated during their synthesis (Figure 1). The 
synthesized Bi
2
O
3
 NPs remained stable at room temperature 
for 15 days, and no visible trace of carbonation was observed, 
since the suspended particles in water kept their yellowish color. 
This established that the antimycotic and antibiofilm properties 
were associated only with the presence of Bi
2
O
3
 NPs.
Antimycotic activity of Bi2O3 NPs 
against C. albicans growth
To explore the possible antifungal activity of Bi
2
O
3
 NPs, their 
effect on C. albicans growth was determined. The results 
showed that Bi
2
O
3
 NPs reduced the number of fungi by 85%, 
in comparison with the control fungi grown in medium. At 
the same time, the treatment with 2% chlorhexidine and 
1% terbinafine (inhibition controls) showed a 44% and 
51% of reduction in the number of fungi, respectively, 
when compared with nontreated cells. The antifungal effect 
of Bi
2
O
3
 NPs was two times better when compared with the 
bulk Bi
2
O
3
 material (Figure 2), suggesting that nanostructured 
Bi
2
O
3
 is more effective as an antifungal agent.
Determination of minimal inhibitory 
concentration of Bi2O3 NPs
In order to characterize the antifungal activity of Bi
2
O
3
 NPs, 
we determined their MIC. The result obtained was 1.5 mM 
(Figure 3). This result is important to know as it represents the 
minimal quantity of Bi
2
O
3
 NPs that is required to effectively 
interfere with C. albicans growth.
Biofilm inhibitory activity of Bi2O3 NPs
In the previous experiment, we measured the antimycotic 
activity of Bi
2
O
3
 NPs. In order to analyze the possible 
biofilm inhibition of C. albicans by bismuth nanoclusters, 
the antibiofilm activity of Bi
2
O
3
 NPs was determined by 
fluorescence microscopy. The results showed a complete 
inhibition of biofilm formation by chlorhexidine (Figure 4B), 
terbinafine (Figure 4C), and Bi
2
O
3
 NPs (Figure 4D), compared 
with the control (Figure 4A). The results did not change when 
Bi
2
O
3
 NPs were added at different postinoculation times – 
we tested the biofilm inhibitory activity at 6 and 18 hours 
postinoculation, obtaining similar results (data not shown). 
These data indicate that Bi
2
O
3
 NPs have an antibiofilm activity 
that is as effective as chlorhexidine and terbinafine.
Cytotoxicity of Bi2O3 NPs in culture cells, 
by fluorescence microscopy
The cytotoxic effect of Bi
2
O
3
 NPs was evaluated in monkey 
kidney (Vero) cells by fluorescence microscopy. The results 
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Figure 2 Antifungal activity of bismuth oxide nanoparticles against Candida albicans 
growth. 
Notes: The y axis shows the optical density units of C. albicans growth. C. albicans 
culture without inhibitor was used as the growth control, whereas chlorhexidine 
2%, terbinafine 1%, Bi2O3 (bulk material), and Bi(NO3)3 ⋅ 5H2O were used as positive 
inhibition controls. For these experiments, we used a concentration of 2 mM of the 
respective bismuth species. 
Abbreviations: Bi2O3, bismuth oxide; Bi(NO3)3 ⋅ 5H2O, bismuth nitrate pentahy- 
drate; NP, nanoparticle.
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Figure 3 MIC of bismuth oxide nanoparticles against Candida albicans growth.
Notes: The y axis shows the optical density units of C. albicans growth; the x 
axis shows the different concentrations of Bi2O NPs analyzed. C. albicans culture 
without inhibitor was used as a growth control. Experiments were carried out three 
times and each time by triplicate. Average results were obtained from the three 
independent experiments. 
Abbreviations: Bi2O3, bismuth oxide; MIC, minimal inhibitory concentration; 
NP, nanoparticle.
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showed that Bi
2
O
3
 NPs did not promote cytotoxic effects in 
the Vero cells at 24 hours of exposure compared with the cells 
without NP. The nuclei and, indeed, all the cells looked very 
similar in the presence or absence of Bi
2
O
3
 NPs (Figure 5). 
These results suggest the absence of cytotoxicity by Bi
2
O
3
 
NPs, under our experimental conditions.
Discussion
In this study, we presented evidence of the antimycotic 
activity of Bi
2
O
3
 NPs. Their efficacy in inhibiting C. albicans 
growth was significantly better than that of chlorhexidine, 
nystatin, and terbinafine. These results indicate that Bi
2
O
3
 
NPs are better antifungal agents than the most commonly 
used oral antiseptic and commercial antifungal agents. 
To be assured that the antifungal effect was due to the 
nanostructured Bi
2
O
3,
 this was compared with the antifungal 
effect of bulk Bi
2
O
3
. The Bi
2
O
3
 NPs were two times more 
effective than the polycrystalline Bi
2
O
3
 in inhibiting 
fungal growth. This result was very important because 
it demonstrated the effectiveness of the nanostructured 
material versus the same bulk compound. Bismuth salicylate, 
a typical molecular bismuth derivative, has been employed to 
treat fungal infections but was not shown to inhibit the fungal 
growth,23 suggesting that it is the nanostructured particle 
of Bi
2
O
3
 that is conferred with the antimicrobial properties 
described earlier.15 These results suggest that Bi
2
O
3
 NPs 
could be very interesting antifungal agents. Previously, it 
was reported that zinc, titanium, and silver NPs have very 
good antifungal activity;24–26 however, it is not possible to 
establish any quantitative antibiofilm activity comparison, 
due to the type of published results.
Inorganic nanostructures have many applications in 
fields like the biological sciences and medicine. NPs have 
been applied as coating materials and in treatments and 
diagnosis.27 NPs of titanium dioxide, silver, diamonds, iron 
oxides, carbon nanotubes, and biodegradable polymers have 
all been studied for their use in diagnosis and treatments. NPs 
of silver, copper oxides, and selenium have been reported to 
have antimicrobial activity.28–30 The advantages of inorganic 
NPs are their high surface-to-volume ratios, different shapes, 
many structural defects, (the presence of irregularities in the 
crystal lattice of the nanostructured bismuth oxide) and of 
course, their nanoscale size, which allows more active sites 
to interact with biological systems such as bacteria, fungi, 
and viruses. This is the most important difference between 
NPs and the typical organic molecular antimicrobial agents, 
and could minimize the risk of developing antimicrobial 
resistance.
The mechanism of the antimicrobial activity of inorganic 
NPs is not completely understood, and their precise mechanism 
of action against bacteria and fungi remains to be fully eluci-
Figure 4 Inhibition of Candida albicans biofilm detected by fluorescence microscopy, 
after 24 hours. As a growth control, C. albicans was added to culture media; 
chlorhexidine 2% and terbinafine 1% were employed as positive inhibition controls. 
In these experiments, we used a concentration of 2 mM Bi2O3 NPs. (A) growth 
control; (B) chlorhexidine; (C) terbinafine; and (D) Bi2O3 NPs. 
Note: The bar indicates 1 µm. 
Abbreviations: Bi2O3, bismuth oxide; NP, nanoparticle.
Figure 5 Cytotoxicity of bismuth oxide nanoparticles detected by fluorescence microscopy. The possible cytotoxic effect of bismuth oxide nanoparticles was evaluated in 
monkey kidney cells by staining the nuclei with DAPI and visualizing cell morphology with DIC. As positive control, Vero cells were used. (A) Positive control and (B) Vero 
cells, after interacting with bismuth oxide nanoparticles, for 24 hours. 
Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; DIC, differential interference contrast microscopy.
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dated. It has been shown that positive charges on the metal ion 
are critical for the antimicrobial activity, allowing for the elec-
trostatic attraction between a negatively charged cell membrane 
and the positively charged NPs.31 It has also been reported that 
silver NPs can damage DNA, alter gene expression, and affect 
the membrane-bound respiratory enzymes.32–34
As previously mentioned, Bi
2
O
3
 has a marked basic 
character, and when this compound is suspended in water, it 
tends to be associated with hydroxyl ions and water molecules 
on its surface, similar to titanium dioxide, zinc oxide, tin dioxide, 
and other metal oxides.35–39 When Bi
2
O
3
 is nanostructured, its 
ionic character is enhanced compared with the same bulk 
material, ie, it becomes a “harder” species with respect to its 
electrons (according to Pearson’s theory of hard and soft acids 
and bases).40 As a consequence, when Bi
2
O
3
 is nanostructured, 
its dissociating character increases, as does the overall surface 
of the material. Therefore, the amount of OH–1 ions and water 
molecules bound to the surfaces of the nanocrystallites is higher 
than in the same bulk material, as is sketched in (Figure 1D). 
Thus, Bi
2
O
3
 NPs dispersed in water are a chemical species with 
a highly negative surface electric potential; subsequently, these 
nanostructured species are strongly basic aggregation points, 
conferring them with a lethal character for the immersed C. 
albicans fungi. It has been reported that several microorganisms 
are very sensitive to alkaline media, among them, C. albicans.41 
We suggest that this is the basis for the fungicidal character of 
Bi
2
O
3
 nanoclusters. Additionally, we cannot discard antifungal 
activity mechanisms involving free radicals, due to the presence 
of CO
2
 in the culture media42 and the inherent α-Bi
2
O
3
 NPs 
photocatalytic properties.43 However, more experimental 
evidences are needed to support these hypotheses.
In parallel to their antifungal activity, the Bi
2
O
3
 NPs 
had the potential to interfere with biofilm formation of C. 
albicans. This antibiofilm activity of the Bi
2
O
3
 NPs was also 
studied. Surprisingly, the antibiofilm formation effect was 
complete in the media with the Bi
2
O
3
 NPs. This effect was 
unexpected since Bi
2
O
3
 NPs only reduced cell growth and 
did not completely inhibit it. To explain this observation, we 
suggest that 85% of cells were inactivated during inoculation 
with Bi
2
O
3
 NPs and that surviving cells were insufficient 
to build a biofilm. It may be that they went into planktonic 
and stress states due the presence of the Bi
2
O
3
 NPs, and it is 
possible that they were lost during the wash of dye excess. 
In the presence of chlorhexidine and Bi
2
O
3
 NPs, we only 
observed (via fluorescence microscopy) cellular debris on 
a dark background – mainly DNA of dead fungus with 
accumulates of dye. Morphologically, these dye accumulates 
clearly differed from fungal biofilm.
It is noteworthy that there are published reports of fungal 
growth inhibition, including inhibition of C. albicans, where 
inorganic NPs, such as diamond-, silver-, gold-, platinum-, 
and palladium-based NPs, were used as antifungal agents.44 
Particularly, silver (Ag) NPs have also been shown to inhibit 
yeast growth,31 and their antifungal activity against certain 
species of Candida45 is well documented. These studies show 
evidence for the molecular mechanism of Ag NPs activity, 
whereby Ag NPs act on and inhibit a number of oxidative 
enzymes, such as yeast alcohol dehydrogenase, through the 
generation of reactive oxygen species.31 Ag NPs have been 
demonstrated to exhibit a desirable and promising antifungal 
effect in several studies, with no serious side effects to the 
host.46 However, the results and the experimental conditions 
used in the aforementioned studies are not comparable with 
those of this research.
The possible cytotoxic effect of Bi
2
O
3
 NPs was explored 
in monkey kidney (Vero) cells by fluorescence microscopy. 
No change was detected in the morphology of the nuclei or, 
indeed, of all cells in the presence or absence of Bi
2
O
3
 NPs, 
suggesting the lack of cytotoxic effect after 24 hours of 
exposure. Earlier, the toxicity of metal oxide NPs, mainly Ag 
oxide (Ag
2
O), zinc oxide (ZnO), and iron oxide (Fe
2
O
3
),47 was 
reported. The possible toxicity of Bi
2
O
3
 NPs was analyzed 
using the same concentration of NPs as was employed in 
those antifungal assays. The preliminary results of this study 
reveal no cytotoxicity of colloidal Bi
2
O
3
 NPs, at least under 
the experimental conditions previously described. This lack 
of cytotoxicity can be attributed to the very small amount of 
inorganic nanomaterial that interacted with the Vero cells. 
The total Bi
2
O
3
 nanocluster mass and doses of 0.15 µg/mL 
introduced were not enough to cause cell damage.
For particle toxicity, three factors are crucial: size, shape, 
and chemical composition. A reduction in the size of a 
nanosized particle results in an increase in the specific surface 
area of the nanostructured powder. Therefore more chemical 
species may attach to its surface, which enhances its reactivity 
and results in an increase in its toxic effects.48,49
In this case, the colloidal Bi
2
O
3
 NPs had a relatively small 
size; however, the number of nanoclusters introduced into the 
Vero cell culture medium, was significantly low compared 
with the total loads of the other two derivatives of bismuth 
(Bi
2
O
3
 in bulk form and bismuth nitrate).
In this work we focused on the effectiveness of Bi
2
O
3
 
NPs in inhibiting the growth of C. albicans. All together, 
the experimental data suggest that Bi
2
O
3
 NPs could be an 
interesting alternative to combat the fungal infections at the 
origin of biofilms. The property of Bi
2
O
3
 NPs could be used in 
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oral health, supporting the antifungal activity of oral antiseptics. 
Further experiments will be necessary to determine the possible 
toxicity of Bi
2
O
3
 NPs and analyze the genotoxicity (apoptosis, 
DNA fragmentation, DNA damage) in human fibroblasts 
cultures and analyze their potential use in humans.
In conclusion, Bi
2
O
3
 NPs of 77 nm average size have an 
antimycotic activity inhibiting the growth of C. albicans, as 
well as an antibiofilm activity. This behavior is different from 
the one of the corresponding bulk material; so, the observed 
activity is a size-dependent property, an explanation that was 
proposed first time. Additionally, our results suggest that the 
Bi
2
O
3
 NPs, under the experimental tested conditions and 
concentrations, do not exhibit cytotoxicity.
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